The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doisne, J.-M.
Right arrow Articles by Venet, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doisne, J.-M.
Right arrow Articles by Venet, A.
The Journal of Immunology, 2004, 173: 2410-2418.
Copyright © 2004 by The American Association of Immunologists

CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1

Jean-Marc Doisne*, Alejandra Urrutia*, Christine Lacabaratz-Porret*, Cécile Goujard{dagger}, Laurence Meyer{ddagger}, Marie-Laure Chaix§, Martine Sinet* and Alain Venet*

* Institut National de la Santé et de la Recherche Médicale E0109, {dagger} Service de Médecine Interne, and {ddagger} Institut National de la Santé et de la Recherche Médicale Unité 569, Hôpital Bicêtre, Le Kremlin-Bicêtre, and § Laboratoire de Virologie Hôpital Necker, Paris, France

Primary viral infections, including primary HIV infection, trigger intense activation of the immune system, with marked expansion of CD38+CD8+ T cells. Whether this expansion involves only viral-specific cells or includes a degree of bystander activation remains a matter of debate. We therefore examined the activation status of EBV-, CMV-, and influenza virus (FLU)-specific CD8+ T cells during primary HIV infection, in comparison to HIV-specific CD8+ T cells. The activation markers CD38 and HLA-DR were strongly expressed on HIV-specific CD8+ T cells. Surprisingly, CD38 expression was also up-regulated on CD8+ T cells specific for other viruses, albeit to a lesser extent. Activation marker expression returned to normal or near-normal values after 1 year of highly active antiretroviral therapy. HIV viral load correlated with CD38 expression on HIV-specific CD8+ T cells but also on EBV-, CMV-, and FLU-specific CD8+ T cells. In primary HIV infection, EBV-specific CD8+ T cells also showed increased Ki67 expression and decreased Bcl-2 expression, compared with values observed in HIV-seronegative control subjects. These results show that bystander activation occurs during primary HIV infection, even though HIV-specific CD8+ T cells express the highest level of activation. The role of this bystander activation in lymphocyte homeostasis and HIV pathogenesis remains to be determined.




This article has been cited by other articles:


Home page
J. Immunol.Home page
W. A. Burgers, C. Riou, M. Mlotshwa, P. Maenetje, D. de Assis Rosa, J. Brenchley, K. Mlisana, D. C. Douek, R. Koup, M. Roederer, et al.
Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point
J. Immunol., April 15, 2009; 182(8): 4751 - 4761.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Lecuroux, I. Girault, A. Urrutia, J.-M. Doisne, C. Deveau, C. Goujard, L. Meyer, M. Sinet, and A. Venet
Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection
Blood, April 2, 2009; 113(14): 3209 - 3217.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Catalfamo, M. Di Mascio, Z. Hu, S. Srinivasula, V. Thaker, J. Adelsberger, A. Rupert, M. Baseler, Y. Tagaya, G. Roby, et al.
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells
PNAS, December 16, 2008; 105(50): 19851 - 19856.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Tuuminen, E. Kekalainen, S. Makela, I. Ala-Houhala, F. A. Ennis, K. Hedman, J. Mustonen, A. Vaheri, and T. P. Arstila
Human CD8+ T Cell Memory Generation in Puumala Hantavirus Infection Occurs after the Acute Phase and Is Associated with Boosting of EBV-Specific CD8+ Memory T Cells
J. Immunol., August 1, 2007; 179(3): 1988 - 1995.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Saez-Cirion, C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia, F. Boufassa, F. Barre-Sinoussi, J.-F. Delfraissy, M. Sinet, G. Pancino, et al.
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
PNAS, April 17, 2007; 104(16): 6776 - 6781.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Petrovas, Y. M. Mueller, I. D. Dimitriou, S. R. Altork, A. Banerjee, P. Sklar, K. C. Mounzer, J. D. Altman, and P. D. Katsikis
Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8+ T cells
Blood, March 15, 2007; 109(6): 2505 - 2513.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Masopust, K. Murali-Krishna, and R. Ahmed
Quantitating the Magnitude of the Lymphocytic Choriomeningitis Virus-Specific CD8 T-Cell Response: It Is Even Bigger than We Thought
J. Virol., February 15, 2007; 81(4): 2002 - 2011.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. Samri, C. Durier, A. Urrutia, I. Sanchez, H. Gahery-Segard, S. Imbart, M. Sinet, E. Tartour, J.-P. Aboulker, B. Autran, et al.
Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay
Clin. Vaccine Immunol., June 1, 2006; 13(6): 684 - 697.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al.
Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection
Blood, September 1, 2005; 106(5): 1660 - 1667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.